Roche to Help Simulations Plus Develop Drug Interaction Software

Jul 28, 2008

NEW YORK (GenomeWeb News) – Simulations Plus said today that it has signed a multi-year collaboration pact with Hoffmann La Roche, under which the pharmaceutical firm will provide funding and feedback in developing the firm’s GastroPlus software program for drug-drug interaction studies.

Lancaster, Calif.-based Simulations Plus said Roche would provide funding for the equivalent of one full-time scientist for two years.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Edited Oil in Use

Oil made from gene-edited soybeans is already in use, according to the Associated Press.

PGx Philanthropy

USA Today reports that Department of Veterans Affairs is teaming up with Sanford Health to provide veterans with genetic testing.

"Wild West"

Mother Jones reports there are few regulations overseeing the use of genetic genealogy by law enforcement.

This Week in Science

In Science this week: analysis of ancient DNA recovered from Iberian populations, and more.

Menu